Lipella Pharmaceuticals Inc.
- Home
- Companies
- Lipella Pharmaceuticals Inc.
- News
- Announcing Radiation (and Hemorrhagic) ...
Announcing Radiation (and Hemorrhagic) Cystitis Patient Registry: for people affected by pelvic radiation during cancer treatment.
May. 8, 2022
Courtesy ofLipella Pharmaceuticals Inc.
Pittsburgh, PA – (May 9, 2022) – Lipella Pharmaceuticals, Inc. is announcing the Radiation Cystitis Patient Registry, an on-line patient registry program for people who are affected by pelvic radiation exposure, including survivors of pelvic cancers, such as prostate, uterine, cervical and colon cancer.
Stay in the loop!
Select your areas of interest to receive industry updates.